December 2015: CTI grant approved

Together with the Adolphe Merkle Institute (AMI), InnoMedica has filed an application for research funding in the amount of CHF 350,000 at the Commission for Technology and Innovation (CTI) of the Swiss Confederation to support a three-year research project. The…

Fall Term Update 2015

Fall Term Update 2015

Thanks to our successful financing round of CHF 1.3 million in May 2015, the InnoMedica team was able to achieve significant progress in several areas in the last few months and to advance the project Talidox further. In addition to…

June 2015: Annual general meeting 2015

June 2015: Annual general meeting 2015

The Board of InnoMedica cordially invites all shareholders to attend the Annual General Meeting 2015. The Annual General Meeting will be held on Wednesday, June 24th  2015 at 04:30 pm (doors open at 04:15 pm) in the conference room of the OBC Suisse…

May 2015: Capital increase successful

The capital increase of InnoMedica was successfully completed on May 26, 2015 and achieved new capital of more than CHF 1.3 million at a share price of CHF 57.50. The response from the audience and the interest in our project confirm…

April 2015: Innomedica at Swiss Biotech Day in Basel

April 2015: Innomedica at Swiss Biotech Day in Basel

April 14th, 2015, InnoMedica will participate at the Swiss Biotech Day. We will present our project Talidox in the Analyst & Investor track with regard to capital increase beginning on March 30, 2015. Come and visit us at our booth! –…

March-May 2015: Capital increase with public offering

March-May 2015: Capital increase with public offering

Capital increase with public offering of 100,000 bearer shares / CHF 5,750,000 The subscription period lasts until 26th of May 2015. The subscription price per new share is CHF 57.50 (denomination min. 200 shares). Order documents for investors now

January 2015: Innomedica now GMP certified by SwissMedic

January 2015: Innomedica now GMP certified by SwissMedic

After inspection of the cleanroom end of November 2014, InnoMedica has now received approval by Swissmedic for the production and wholesale of pharmaceuticals for the next 5 years. This includes the processing of highly active or allergic drugs (cytostatics) and…

December 2014: TV feature story about Talidox

In October 2014, the TV channel of the french speaking part of switzerland RTS broadcasted about InnoMedica as part of a news report about the Marly Innovation Center. On 25 December 2014, a detailed report on InnoMedica and Talidox was aired…

October 2014: Innomedica in the News on RTS

October 2014: Innomedica in the News on RTS

A short TV-report of our production site in Marly shows InnoMedica’s clean room for production. Click here to view the clip.

September 2014: Innomedica at Sachs Forum in Basel

September 2014: Innomedica at Sachs Forum in Basel

InnoMedica presents itself and the project TLD-1 at the 14th Biotech in Europe Forum for Global Partnering & Investment of SACHS Associates on September 30st 2014 in Basel: short presentation by Jonas Zeller, direct exchange with the team at the InnoMedica both. The SACHS…